Markers proposed to be related to increased disease activity and/or severity. ‡ Markers that have been associated with Behcet's disease. § Innate immunity. AB: Antibody; ACA: Anticardiolipin ...

Hypopyon Figure 5, once considered a hallmark of Behçet disease, is seen much less commonly than fundus lesions. It was noted in only 12% of 1567 eyes. [17] Vitreous: vitritis, haze Figure 6 ...

Professor Fortune’s team discovered that clotting happens because of disease related endothelial and platelet activation, explaining why anticoagulants are ineffective. As a result, treatment ...

Considering taking supplements to treat behcet disease? Below is a list of common natural remedies used to treat or reduce the symptoms of behcet disease. Follow the links to read common uses ...

Keep abreast with the latest news related to Behcet's Syndrome there are 11 news items on Behcet's Syndrome that covers updates, breakthroughs and in-depth reports. We provide you with a free ...

Phase 2 Trial of SGX945 in Behcet’s Disease Initiates On November 14, 2024, Soligenix announced the initiation of the Phase 2 trial of SGX945 (dusquetide) for the treatment of Behcet’s disease.